ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.035 AUD -2.78%
Market Cap: 71.3m AUD

Wall Street
Price Targets

IPD Price Targets Summary
ImpediMed Ltd

Wall Street analysts forecast IPD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IPD is 0.109 AUD with a low forecast of 0.071 AUD and a high forecast of 0.137 AUD.

Lowest
Price Target
0.071 AUD
102% Upside
Average
Price Target
0.109 AUD
211% Upside
Highest
Price Target
0.137 AUD
290% Upside
ImpediMed Ltd Competitors:
Price Targets
214150
Classys Inc
26% Upside
GEHC
GE Healthcare Technologies Inc
9% Upside
DRIO
DarioHealth Corp
54% Upside
MX1
Micro-X Ltd
106% Upside
300482
Guangzhou Wondfo Biotech Co Ltd
34% Upside
PRN
Profound Medical Corp
50% Upside
4543
Terumo Corp
38% Upside
HYPR
Hyperfine Inc
77% Upside

Revenue
Forecast

Revenue Estimate
ImpediMed Ltd

For the last 13 years the compound annual growth rate for ImpediMed Ltd's revenue is 11%. The projected CAGR for the next 3 years is 63%.

11%
Past Growth
63%
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ImpediMed Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
ImpediMed Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-79%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IPD's stock price target?
Price Target
0.109 AUD

According to Wall Street analysts, the average 1-year price target for IPD is 0.109 AUD with a low forecast of 0.071 AUD and a high forecast of 0.137 AUD.

What is ImpediMed Ltd's Revenue forecast?
Projected CAGR
63%

For the last 13 years the compound annual growth rate for ImpediMed Ltd's revenue is 11%. The projected CAGR for the next 3 years is 63%.

Back to Top